These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 16208781)
21. Role of growth factors in improved skin flap viability caused by phosphodiesterase-5 inhibitor. Bandera BC; Pham T; Hill-Pryor C; Bah-Sow M; Franco N; Prasad BM; Pizarro J Am Surg; 2010 Jun; 76(6):614-7. PubMed ID: 20583517 [TBL] [Abstract][Full Text] [Related]
22. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841 [TBL] [Abstract][Full Text] [Related]
23. Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects. Polak K; Wimpissinger B; Berisha F; Georgopoulos M; Schmetterer L Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4872-6. PubMed ID: 14578411 [TBL] [Abstract][Full Text] [Related]
24. Does sildenafil indirectly inhibit phosphodiesterase 3 in vascular smooth muscle? Maurice DH Hypertension; 2003 Mar; 41(3):e2. PubMed ID: 12623968 [No Abstract] [Full Text] [Related]
25. Short- and long-term effects of sildenafil on skin flap survival in rats. Hart K; Baur D; Hodam J; Lesoon-Wood L; Parham M; Keith K; Vazquez R; Ager E; Pizarro J Laryngoscope; 2006 Apr; 116(4):522-8. PubMed ID: 16585853 [TBL] [Abstract][Full Text] [Related]
26. Interaction of sildenafil with cAMP-mediated vasodilation in vivo. Schalcher C; Schad K; Brunner-La Rocca HP; Schindler R; Oechslin E; Scharf C; Suetsch G; Bertel O; Kiowski W Hypertension; 2002 Nov; 40(5):763-7. PubMed ID: 12411474 [TBL] [Abstract][Full Text] [Related]
27. Modulation of paracetamol-induced hepatotoxicity by phosphodiesterase isozyme inhibition in rats: a preliminary study. Ekor M; Odewabi AO; Kale OE; Bamidele TO; Adesanoye OA; Farombi EO J Basic Clin Physiol Pharmacol; 2013; 24(1):73-9. PubMed ID: 23425627 [TBL] [Abstract][Full Text] [Related]
28. Phosphodiesterase-5 inhibition by sildenafil citrate in a rat model of bleomycin-induced lung fibrosis. Yildirim A; Ersoy Y; Ercan F; Atukeren P; Gumustas K; Uslu U; Alican I Pulm Pharmacol Ther; 2010 Jun; 23(3):215-21. PubMed ID: 19945540 [TBL] [Abstract][Full Text] [Related]
29. Sex and the patient with cardiovascular risk factors: focus on sildenafil. Kloner RA Am J Med; 2000 Dec; 109 Suppl 9A():13S-21S; discussion 29S-30S. PubMed ID: 11137498 [TBL] [Abstract][Full Text] [Related]
30. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway. Andric SA; Janjic MM; Stojkov NJ; Kostic TS Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985 [TBL] [Abstract][Full Text] [Related]
31. Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy. Sasser JM; Baylis C Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R433-8. PubMed ID: 19955496 [TBL] [Abstract][Full Text] [Related]
32. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Jeremy JY; Ballard SA; Naylor AM; Miller MA; Angelini GD Br J Urol; 1997 Jun; 79(6):958-63. PubMed ID: 9202566 [TBL] [Abstract][Full Text] [Related]
33. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects. Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324 [TBL] [Abstract][Full Text] [Related]
34. Sildenafil citrate (Viagra) enhances vasodilatation by atrial natriuretic peptide in normal dogs. Ishikura F; Beppu S; Asanuma T; Seward JB; Khandheria BK Circ J; 2007 Dec; 71(12):1965-9. PubMed ID: 18037755 [TBL] [Abstract][Full Text] [Related]
35. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Rodríguez-Iturbe B; Ferrebuz A; Vanegas V; Quiroz Y; Espinoza F; Pons H; Vaziri ND Kidney Int; 2005 Nov; 68(5):2131-42. PubMed ID: 16221212 [TBL] [Abstract][Full Text] [Related]
36. Effect of sildenafil citrate on an orthotopic prostate cancer growth and metastasis model. Qian CN; Takahashi M; Kahnoski R; Teh BT J Urol; 2003 Sep; 170(3):994-7. PubMed ID: 12913757 [TBL] [Abstract][Full Text] [Related]
37. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence. Traish A; Kim N J Sex Med; 2008 Jul; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281 [No Abstract] [Full Text] [Related]
38. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. Halcox JP; Nour KR; Zalos G; Mincemoyer RA; Waclawiw M; Rivera CE; Willie G; Ellahham S; Quyyumi AA J Am Coll Cardiol; 2002 Oct; 40(7):1232-40. PubMed ID: 12383570 [TBL] [Abstract][Full Text] [Related]
39. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues. Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Aziz AT J Sex Med; 2008 Jul; 5(7):1636-45. PubMed ID: 18208506 [TBL] [Abstract][Full Text] [Related]
40. The effect of sildenafil on ocular blood flow. Harris A; Kagemann L; Ehrlich R; Ehrlich Y; López CR; Purvin VA Br J Ophthalmol; 2008 Apr; 92(4):469-73. PubMed ID: 18369062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]